<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039804</url>
  </required_header>
  <id_info>
    <org_study_id>Trochanter Bursitis</org_study_id>
    <nct_id>NCT02039804</nct_id>
  </id_info>
  <brief_title>Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.</brief_title>
  <official_title>Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trochanteric pain can be caused by osteoarthritis of the hip, fracture, tendinitis, nerve
      pathology and trochanteric bursitis. Trochanteric bursitis is often seen at the outpatient
      clinic and is characterized by chronic lateral hip pain in the vicinity of the trochanter
      major, overlying the lateral aspect of the hip. When pain is persistent after conventional
      therapies, anesthetic and corticosteroid (CS) injections can provide short term to
      intermediate relief of pain, but relapse is common. Only one retrospective study showed the
      efficacy of intra-bursal trochanteric injections with HA and CS. They concluded that the pain
      release is significant with large effect sizes for both treatment. However, the efficacy of
      CS appeared to be short lived and it was shown that the efficacy of HA at 6 and 12 months is
      significant compared to CS (p&lt;0.05).

      In this study we want to compare the efficacy of corticosteroids and hyaluronic acid in the
      treatment of trochanteric bursitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS for pain</measure>
    <time_frame>26 weeks after administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>6, 12, 26 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS for pain</measure>
    <time_frame>6 and 12 weeks after administration</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient's Global Assessment of Normal Function/Activity</measure>
    <time_frame>6, 12, 26 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injectable hyaluronic acid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corticosteroids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injectable corticosteroids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroids</intervention_name>
    <description>Intra-bursal injection</description>
    <arm_group_label>Corticosteroids</arm_group_label>
    <other_name>Depo-Medrol 40mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>Intra-bursal injection</description>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <other_name>SportVis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, 18 years and older, but &lt;75 years;

          -  VAS for pain &gt; 30mm;

          -  Diagnosis of trochanteric bursitis as suggested by Brinks et al with symptoms for more
             than 3 months (3);

          -  Failure of conservative therapy of more than one month;

          -  Written informed consent;

          -  Available for the duration of the investigation.

        Exclusion Criteria:

          -  Previous surgery in the same region;

          -  Current other problem(s) in the affected extremity;

          -  Diabetes mellitus;

          -  Patient who received a local (CS) injection within 3 months from the baseline visit;

          -  Allergic or hypersensitive to CS or HA;

          -  Patients suffering (chronic) low back pain with or without sciatic pain;

          -  Patients with radiographic signs of moderate or severe hip osteoarthritis (Kellgren
             and Lawrence &gt;1);

          -  Pregnant or lactating, or woman of childbearing potential not willing to use an
             acceptable method of contraception during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sascha Colen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sascha Colen, MD</last_name>
    <phone>0032-497180798</phone>
    <email>sascolen@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3212</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sascha Colen, MD</last_name>
      <phone>00497-180798</phone>
      <email>sascolen@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2013</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2014</study_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Dr. Sascha Colen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

